India Rejects Abbott Lab’s Patent Application for HIV Drug

4 Jan 2011

India has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving medication for HIV patients across the globe. The Economic Times

Learn more about how you can help build a more equitable system for all